• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Jack Ansell, MD, Discusses the STABLE Study

Article

The STABLE study compared patients who took weekly tests compared with those who tested less regularly, and found that those who tested weekly had better results than those who did not.

The STABLE study was done to show how warfarin testing worked in a “real world” setting, according to Jack Ansell, MD, lead study investigator and professor of Medicine at Hofstra-North Shore/LIJ School of Medicine. The study compared patients who took weekly tests compared with those who tested less regularly, and found that those who tested weekly had better results than those who did not. In fact, Dr Ansell said, the results for patients testing weekly had better average time in therapeutic range (TTR) than found in most clinical trials. Read the article here.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Pierluigi Porcu, MD
Benjamin Chen, MD, PhD
Kimberly Westrich, MA, chief strategy officer, NPC
Erin Weber, MS
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Marla Black Morgan, MD, Phoebe Neurology Associates
Elizabeth Grush, MBA
Raj Chovatiya, MD, PhD, MSCI.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.